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ABSTRACT 
 
Introduction: Cervical cancer exists as the second most common cancer among 
women world wide, and in numerous countries is the leading type of female 
cancer. Specifically, Zambia has one of the highest mortality rates and cervical 
cancer incidence rates. The goal of this study is to analyze the published 
literature on preventative techniques for cervical cancer in resource-deprived 
areas of sub-Saharan Africa by focusing on the correlation between the Human 
Papilloma Virus (HPV), Acquired Immunodeficiency Syndrome (AIDS), and 
cervical cancer; the accuracy and feasibility of “screen and treat” clinics; and 
socio-economic and geographical barriers.  
Results: Correlations exists between the prevalence of HIV, HPV, and cervical 
cancer in sub-Saharan Africa, and a clear association exists between HPV and 
cervical cancer. The deliverance of HPV vaccines as well as educational 
programs has helped to improve this medical problem. Main screening methods 
for cervical cancer include the Pap smear, naked eye visual inspection of the 
cervix after the application of either diluted acetic acid (VIA), Lugol’s iodine (VILI), 
 v 
or with a magnifying device (VIAM), colposcopy, and tests for HPV markers. 
Studies indicate that the VILI screening test has the highest level of sensitivity 
with the LEEP method also of importance. The procedure is relatively low cost 
and is easy to implement when excising lesions. Major risk factors and 
determinants of cervical cancer can help to explain the underlying barriers of 
access to care. Women’s misconceptions regarding cervical cancer, gender 
inequality in African nations, socio-economic status, and foreign aid all play major 
roles the cervical cancer screening process. A lack of proper education, 
especially among women in sub-Sahara Africa, has led to misconceptions about 
the causes of cervical cancer. Studies have found that some women associated 
cervical cancer with prostitution, a Satanic curse, and other bad behavior.  
Gender inequality also plays a significant role since the Zambia government had 
reported that a husband would have absolute rights over children and 
reproductive rights over his wife once he had made payments for a bride. 
Geographical barriers also exist as the terrain in Zambia is swamp-like and 
heavy flooding throughout the year is common. After flooding occurs, 
communities become physically separated. Furthermore, there are correlations 
between high incidence rates of cervical cancer and high poverty as it has been 
shown that the largest number of people living on less than $1.25 dollars per day 
is that of sub-Saharan Africa.  
Discussion: Studies have indicated that virtually all of cases of cervical cancer 
are caused by HPV, implying that HPV testing and detection would largely 
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prevent the progression of lesions. Ultimately, this would reduce the high 
incidence rate of cervical cancer in Zambia and in other Sub-Saharan African 
countries.  In areas where cytology programs are either non-existent or not 
efficient, HPV testing approaches should be evaluated and implemented, and 
they should be based off of the HIV/AIDS infrastructure that has already been 
established.  In regards to the screening approaches, VIAM and VIA are the only 
two tests that are also practical, affordable, and available. Affordability is the 
major concern when implementing screening programs in sub-Saharan Africa; for 
this reason, either VIAM and VIA would arguably be the best options as long as 
they were effective.  VIA would be considered the most appropriate method in 
terms of screening procedures as the method has the advantage of giving 
immediate results that can be applied to large populations. Lastly, the lack of 
proper education, including sex education, has in part led to drastic 
misconceptions about the causes of cervical cancer. Women hold negative 
beliefs about cervical cancer since they associate it with being unclean and view 
it as a reflection of bad behavior. Geographical barriers also play a role; the 
physical inaccessibility of the clinic discourages women to come to the clinic for 
screenings. Home visits by physicians and/or the utilization of community health 
workers may help to eliminate this particular barrier of access. This strategy 
would be especially beneficial to residents of rural areas since they are more 
likely to live farther away from institutionalized clinics and screen and treat 
facilities and are also more likely to be in a state of extreme poverty.  
 vii 
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INTRODUCTION 
 
Cervical Cancer 
 Cervical cancer exists as the second most common cancer among women 
world wide, and in numerous countries is the leading type of female cancer (24). 
As seen in Figure 3, cervical cancer is most prevalent on the South American 
continent as well as the western and southeastern portions of Africa (24).  
Worldwide, an estimated 500,000 women are diagnosed with cervical cancer, 
and over half of the women diagnosed die from the cancer; additionally, nearly 
80% of these women live in resource-deprived countries (12). More specifically, 
Zambia has one of the highest mortality rates and cervical cancer incidence rates 
world-wide (12). Anatomically, the cervix of the female provides an opening that 
allows for communication between the vagina and uterus, and the outer surface 
of the cervix is the region in which squamous epithelium develop during the early 
stages of cervical cancer (28).  Sexual contact is one of the most widespread 
methods of transmission of cervical cancer (25).  Human Papilloma Virus, HPV, 
is one of the most common causes of sexually transmitted diseases worldwide in 
both men and women. It is associated with a variety of clinical conditions that 
range from innocuous lesions to cancer and was originally linked to cervical 
cancer in the early 1980’s by Hrold zur Hausen (1). Since his demonstration was 
published, the link between HPV and cervical cancer has become well 
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established. The degree of association has been found to be greater than the 
association between smoking and lung cancer (1).   
Transmission of HPV occurs mainly through skin-to-skin contact and is 
heavily influenced by sexual activity. Along with sexual activity, age is an 
extremely important determinant of risk of HPV infection since the greatest risk 
coincides with greatest metaplastic activity within the cervix.  
“Most cervical cancers arise at the squamocolumnar junction 
between the columnar epithelium of the endocervix and the 
squamous epithelium of the ectocervix” (1)  
 
The greatest changes occur at puberty and when a woman becomes pregnant. 
Therefore, HPV infection is typically most common when a woman is sexually 
active, between the ages of 18 and 30. However, cervical cancer seems to be 
most prevalent in the age group of 35 years and older, suggesting that the 
infection occurs at a young age and progresses slowly to cancer. The clinical 
manifestation of HPV can lead to one of three possible fates, including anogenital 
warts, latent or inactive infection in which symptoms are usually not noticeable or 
active infection, which is associated with high-risk developments (1). 
In terms of scientific pathology, the microbiological pathway of HPV 
development can be seen in Figure 1. Ultimately, the HPV oncogenes E6 and E7 
have a high affinity for p53 and pRB. Binding disrupts the normal function of the 
proteins and can lead to continuous proliferation of the virus. The viral infection 
can lead to malignancy and cervical cancer since more DNA becomes damaged 
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and cannot be repaired. More specifically, the high risk- HPV types disrupt 
normal cell protein functions including gene expression (1).   
Several types of malignant cervical tumors exist, the most common being 
squamous cell carcinoma. The carcinomas are scientifically classified into grades 
or stages depending on the severity and spread of the cancer. For instance, 
grade 1 carcinomas include squamous cells with keratin, little pleomorphism, and 
low mitotic rate and grade 2 tumors are a bit more developed and contain greater 
nuclear pleomorphism, high mitotic rate. Grade 3 is considered to have very 
severe nuclear atypia and very little squamous differentiation. Figure 2 below 
exemplifies a more severe cervical adenomcarcinoma. 
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Figure 1:  Pathogenesis of HPV.  The E6 and E7 genes commonly bind to p53 
and pRB proteins.  This leads to altered regulation, function and uultimately 
oncogenic transformation. Figure taken from Burd, 2006 (1). 
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Figure 2 Invasive Endocervical Adenocarcinoma. The development and 
progression of a invasive cervical cancer is depicted in the figure above. Figure 
taken from Silverberg, 2003 (2).   
 
When abnormal cervical changes are observed, a colposcopy is 
performed and cervical tissue samples are examined microscopically (27).  The 
cancer progresses slowly and begins as precancerous dysplasia; if detected 
early enough by a Pap (Papanicolaou) smear test, the condition is 100% 
treatable (27).  Women who are younger than 35 years old have a lower chance 
of survival if their stage of cervical cancer is II or above (2).  The most invasive 
type of carcinoma develops from an intraepithelial neoplasm, forming from within 
the tissues of the cervical ectopy (3). Cervical carcinomas spread from the 
cervical stroma into the parametrial tissues, the uterus, vagina, and can spread 
to the bladder as they progress in the later stages of the disease (3). If left 
untreated, cervical cancer will result in death.   
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Regional Discrepancies 
 Cervix exams and cervical cancer screenings exist as critical elements in 
cancer prevention. Zambia, Ethiopia, and Malawi are amongst the top nations in 
terms of the percentage of women who have never had a pelvic exam (Figure 3) 
(25).  Within a cohort of individuals in Tanzania, for example, only 22.6% of the 
women had ever obtained cervical cancer screening (29).  Reasons for such low 
rates are primarily due to level of education, preconceived notions regarding 
cervical cancer, the spouse’s opinion and approval to get screened, and the 
location in which the screening or exam is being conducted (26).  The majority of 
the studies that have been conducted highlight the extremely elevated rates of 
cervical cancer and the factors that have led to such unfortunate circumstances.  
Screening via the Pap test and other tests can potentially provide 100% 
remission. Furthermore, Pfaendler discusses the clinical significance of the loop 
electrosurgical excision procedure (LEEP) and how it can be managed locally 
and performed safely with low rates of complications when treating cervical 
cancer abroad (12).  Cervical cancer has been a leading concern in African 
nations, but promising solutions do exist. The needle for access to care and 
resources needs to be moved.  
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Figure 3: Incidence Rates of Cervical Cancer World-Wide.  Figure taken from 
World Health Organization, 2009 (24).  
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STUDY OBJECTIVES 
 
As shown in previous studies, it is evident that cervical cancer screening 
via Pap smears and various other screening methods tremendously aid in the 
prevention of cervical cancer. The disparity in the accessibility of care and 
screening between women residing in the U.S. and in third world nations is quite 
alarming. Lack of proper resources, inadequate education and infrastructure, 
misconception about cervical cancer, and numerous other factors contribute to 
the high prevalence of cervical cancer.  
The goal of this study is to analyze the published literature on preventative 
techniques for cervical cancer in resource deprived nations that have barriers to 
healthcare. Specifically, 
(1) The correlation between the Human Papilloma Virus (HPV), Acquired 
Immunodeficiency Syndrome (AIDS), and cervical cancer will be 
analyzed as well as the implications for prevention. 
(2) The accuracy and feasibility of “screen and treat” programs and 
different types of screening procedures from studies conducted in the 
U.S. and worldwide will be examined. 
(3) Barriers such as the level of education, women’s’ misconceptions 
about cervical cancer, gender inequality, resource deprived settings, 
lack of professional medical training, and foreign aid and funding will 
be considered. 
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We hope the findings from this study will bring conclusive information about more 
sound and organized methods for cervical cancer prevention in not only Zambia 
but in similar resource-deprived nations. A proposal will be made in regards to 
broadening the scope in order to target Human Immunodeficiency Virus (HIV), 
HPV and cervical cancer simultaneously, to using the most feasible type of 
screening test, and to finding solutions for the barriers previously stated.  Such 
solutions are vital for the health and well being of individuals in dire need of 
medical attention.  
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PUBLISHED STUDIES 
 
The Correlation Between The Human Papilloma Virus (HPV), Acquired 
Immunodeficiency Syndrome (AIDS), And Cervical Cancer  
A significant correlation and causal relationship between HPV and cervical 
cancer has been determined by several studies. Similarly, the prevalence of 
AIDS has been shown to be indicative of higher risk for the development of 
cervical cancer especially in Sub-Sahara Africa. The most frequently reported 
risk factors for HPV and AIDS have included a high number of sexual partners, 
early age at first intercourse, or any previous sexually transmitted disease (STD) 
(5).  The deliverance of HPV vaccines as well as educational programs has 
helped to improve this medical problem. According to Bosch, epidemiological 
evidence gathered from a large and consistent body of studies have supported 
without doubt the clear association between HPV and cervical cancer (5). This 
can be seen through case control studies and prevalence surveys which show 
that in 90-100% of cases, HPV DNA has been found in adequate specimens of 
cervical cancer, and this is in comparison with a prevalence of 5-20% in cervical 
specimens from women identified as controls in epidemiological studies (5). 
Nearly all of the cervical cancer cases had detectable traces of HPV, indicating a 
strong correlation between HPV and cervical cancer. Among the 50 countries 
that were observed during the study, striking consistency exists, further 
supporting the existence of a meaningful correlation.  The correlations were 
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based upon epidemiological factors including strength of association, 
consistency, and specificity, which asserts that a cause should lead to a single 
effect rather than multiple effects (5). The specificity in this case was very high, 
further supporting the evidence that HPV infection leads to cervical cancer.  
 The human immunodeficiency virus, HIV, can lead to acquired 
immunodeficiency syndrome, more commonly known as AIDS. HIV affects and 
slowly destroys the CD4 cells of the immune system. It can be transmitted 
through vaginal or anal sex or by sharing needles or drug injection materials with 
someone who is already infected with HIV (32). The number of new HIV 
infections, especially among women, in the United States is decreasing primarily 
due to antiretroviral therapy and an increased level of awareness and 
preventative measures; however, Black and African American women are 
disproportionally affected by HIV in the U.S. and in Sub-Sahara Africa (32).  HIV 
is of particular interest when analyzing HPV and cervical cancer trends because 
a great amount of co-prevalence exists between the two viruses. According to a 
comprehensive review in 2009, areas of Sub-Sahara Africa that have the highest 
HIV prevalence rates also have extremely high incidences of cervical cancer, as 
can be seen by Figure 4 (7). The dark red areas indicate areas with an HIV 
prevalence of 20-28% and cervical cancer incidences of the same percentage 
(7). While the prevalence is not exact, patterns in specific areas can be seen, 
indicating some level of correlation.  Whether or not the HIV epidemic has 
affected the incidence of invasive cervical cancer on a grand scale (ICC) in Sub-
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Sahara Africa remains unclear; however, according to Louie, the ICC incidence 
rates have not been reduced significantly between the 1960’s and the 1990s, 
demonstrating that  great need for continued research (Figure 4) (7)  
 
 
Figure 4:  World Incidence of Cervical Cancer and HIV.  Shown are the rates 
of cervical cancer and HIV world-wide per 100,000.  Figure taken from Louie, 
2009 (7). 
 
 
Contrarily, epidemiological studies have consistently shown that women 
who are HIV- infected are at a much higher risk of becoming infected with HPV 
than are HIV-negative women (7).    Furthermore, it has been shown that HIV- 
positive women with ICC are more likely to have more multiple infections than 
that of HIV- negative women (7).  Pfaendler discusses the importance of a study 
conducted in Zambia, which helps to support the claim that HIV-infected women 
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are at a higher risk of becoming infected with HPV. The main cohort enrolled 
included HIV infected women, and it was demonstrated that co-infection with 
HPV and HIV results in increased rates of cervical intraepithelial neoplasia (CIN) 
which in turn is the precursor to cervical cancer (12). All such findings reveal that 
HIV positive women are at higher risk for developing HPV, and ultimately for 
developing cervical cancer (12). Reasons for such risks are not conclusive. 
Studies have proposed that the high prevalence of communicable diseases 
sexually transmitted infections, and sexual behaviors may have an influence 
upon the immune status of women with cervical cancer (ref). In an effort to 
reduce the risky behaviors, Pfaendler’s study included an HIV peer education 
program implemented in Zambia. The Educator Program consisted of five major 
components. Peer educators in the area were trained on how to deliver 
messages in the community regarding the importance of cervical cancer 
screening, especially among HIV-infected women. The peer educators were also 
given daily cervical cancer preventions talks in the HIV care and treatment clinics 
in which cervical cancer prevention services were being offered.  Furthermore, 
the peer educators assisted HIV- positive women to getting to the HPV screening 
clinics (12).  Lastly, the staff members within the HIV- care clinics strongly 
encouraged HIV-infected women to be screened, and the nurses educated 
patients about the potentially deadly risks of cervical cancer (12). The Peer 
Education system helped Zambian women understand the severity of cervical 
cancer as well as the importance of getting screened.  
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Overall, the correlation between HIV, HPV and cervical cancer is very 
apparent, and important measures including the use of anti-retroviral therapy 
(ART), measuring viral load, and the use of HPV vaccines may help to decrease 
the prevalence of cervical cancer, especially among HIV-positive women. 
According to Louie, after the use of ART, the immune system is better able to 
control and recover from HIV- related opportunistic infections, including Kaposi’s 
sarcoma and possibly HPV (7). An important measurement that may help to 
distinguish clinically relevant infections from those that are less severe is 
determining the viral load. This was found by Bosch’s study that  
 
“confirmed that high viral load predicted cervical lesions and… 
the reduction of viral load or clearance of viral DNA in repeated  
visits [and] predicts regression of CIN lesions to normalcy” (5).  
 
 
In essence, high viral load was indicative of more severe and progressive 
forms of cervical cancer. Lastly, the use of HPV vaccines is arguably the 
soundest method to decrease the prevalence of cervical cancer, especially 
among HIV-infected women. The data suggests that HPV vaccines that contain 
the HPV16/18 can potentially prevent invasive cervical cancer cases among HIV-
positive women (5). Therefore, HPV vaccinations are of paramount importance.  
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HPV Vaccines   
 Two main HPV vaccines for women, Cervarix and Gardasil, are licensed 
by the Food and Drug Administration, according to the Center for Disease 
Control and Prevention (CDC) (31). Cervarix is a bivalent HPV vaccine and 
prevents the formation of HPV type 16 and 18, which cause approximately 70% 
of cervical cancers (GlaxoSmithKline, USA) (38). Gardasil is a quadrivalent 
vaccine which prevents HPV types 16,18, 6, and 11 (Merck Sharp & Dohme) 
(39). HPV types 6 and 11 are known to lead to about 90% of genital warts (31). 
The vaccines are intended as a preventative measure and will not treat any 
already existing HPV-related disease. Both Cervarix and Gardasil are generally 
administered in early adolescence as part of a 3 dose regiment (31). Ultimately, 
the vaccinations are recommended for protection against and prevention of 
cervical cancers as well as precancers in young women. Only the quadrivalent 
HPV vaccine is recommended for use of men (31). It is recommended that young 
men and women receive the vaccinations before the onset of sexual activity 
since they may become exposed to HPV during sexual activity (31). While the 
HPV vaccine can prevent severe cases of cervical cancer, the vaccine is 
incredibly expensive. The three-dose vaccine is about 360 U.S. dollars (7). 
Because of the high price, it would especially be difficult to implement vaccination 
services in developing countries including those in Sub-Sahara Africa. Nearly 
80% of cervical cancer cases occur in developing countries, and cost barriers 
need to be overcome in order to initiate the introduction of vaccines (7). Vaccines 
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would be targeted towards women who have not been diagnosed with HPV or 
cervical cancer. However, since many women in Sub-Sahara Africa already 
suffer from HPV and varying degrees of cervical cancer, screen and treat 
programs may be a more suitable approach to improving their health.  
 
The Accuracy And Feasibility Of “Screen And Treat” Programs And 
Different Types Of Screening Procedures From Studies Conducted In The 
U.S. And Worldwide  
 Some of the main types of screening methods for cervical cancer include 
a Pap smear, naked eye visual inspection of the cervix after the application of 
either diluted acetic acid (VIA), Lugol’s iodine (VILI), or with a magnifying device 
(VIAM), HPV testing with the high risk probe of the Hybrid Capture-2 assay 
(HC2), colposcopy, and tests for HPV markers (8). A Pap smear is a screening 
procedure in which the cells within the cervix are examined. A speculum is 
placed into the vagina, allowing it to open slightly. Cells are then gently scraped 
from the cervix and examined microscopically for any traces of cervical cancer or 
HPV (33). Figure 5 below depicts a Pap smear with abnormal squamous cells 
(1).  
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Figure 5:  Abnormal Pap Smear .  Thin Prep Pap Smear indicating abnormal 
squamous cells due to HPV.  Figure taken from Burd, 2006 (1). 
 
 
 
Visual inspection of the cervix may entail either swabbing the cervix with 
acetic acid, which is the VIA method, or using magnification to inspect the cervix, 
which is termed VIAM (9). Similarly, Lugol’s iodine can be applied to the cervix to 
test for cervical cancer. Cervical tissue that may be cancerous does not stain 
upon application of Lugol’s iodine and thus can be identified since it is more pale 
(9). Molecular HPV DNA tests can also be used as screening measures and help 
to detect the presence of the HPV virus prior to developing cancer (9). 
Cervicography, which entails taking pictures of the cervix and submitting them for 
examination by a physician, also exists as a viable option of screening (9). All of 
the screening methods have been shown to be safe and almost all are available 
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in low-resource settings. Table 1 below indicates whether each test is effective, 
practical, affordable, and available.  
 
 
Table 1  Cervical Cancer Screening Approaches.  Various screening 
approaches and their effectiveness in low-resource settings are depicted.  Figure 
taken from Abwao, 1988 (9). 
 
 
 
 
 
Some tests are more reliable than others since they vary in degrees of 
sensitivity and specificity. Sensitivity and specificity are epidemiological terms 
that determine the accuracy of screening measures. Sensitivity indicates the 
proportion of positive screening tests that are actually positive, while specificity 
indicates the proportion of negative screening tests that are actually in fact 
negative (35). An increase in sensitivity of a screening methods will lead to a 
decrease in specificity, and vice versa (35). Concerns have been raised in 
regards to poor sensitivity, which can lead to over-looking cancers, and poor 
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specificity, which can lead to over-treatment. It has been determined that no HPV 
or cervical cancer screening method exists that would be able to attain high 
levels of both sensitivity and specificity (9).  The level of accuracy, cost, and 
overall feasibility of each type of screening test varies to some extent. (9). Arbyn 
conducted a pooled analysis of five cervical cancer-screening tests in order to 
compare the accuracies of each. The tests were assessed in eleven different 
studies in India and Africa, and over 58,000 women were tests (8). Arbyn’s 
findings for the five different types of screening tests, as well as their specificity 
and sensitivity, are summarized in Table 2. According to the data, the screening 
test with the highest level of sensitivity, with 95% of a confidence interval, was 
that of the VILI (8).  
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 A similar study was conducted in Lusaka, Zambia in 2006 and 2007;  
Zambian physicians and nurses were trained to not only perform VIA, but also to 
conduct punch biopsies on women who had been diagnosed with cervical cancer 
(12). The method of LEEP, which stands for loop electrosurgical excision 
procedure, is one of the major types of treatment services offered in developing 
countries (12). The procedure is relatively low cost, has a high success rate, and 
is easy to implement. The procedure entails the use of a thin wire loop that 
functions as a surgical knife. The loop is placed within the cervix, and an electric 
current passes through the loop; this process cuts a fairly thin layer of the cervix 
in an effort to excise and remove the cancerous cells (Figure 6) (36).  
The study conducted in Lusaka, Zambia utilized LEEP, the VIA screen, 
and preventative services in 13 clinics within the region. A very high amount of 
women were diagnosed with cervical cancer. More specifically, 155 of the 
women who had undergone evaluation had CIN I, 144 had CIN II and III, and 149 
had invasive cancer (12). LEEP was performed on almost all of the women. The 
physician training process for LEEP was therefore vital. The major steps of the 
training are depicted in Figure 6, and, overall, it was fairly simple. Four 
physicians were able to complete the procedure with a high level of skill after 
completing the training (12).  LEEP has shown to be very effective in treatment, 
and the entire training for nurses and physicians was thoroughly completed 
within four weeks (12). Other screening methods have been shown to be very 
effective, as well, but their success also depends upon the patient population, 
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community, and terrain of the area in which the screenings will be conducted (7). 
In order to be successful, screening program should be accessible to patients, 
and referral services should be made available. 
 
 
Figure 6:  LEEP Training Process.  Overview of the training process for LEEP 
for physicians, which involves didactic training, direct supervision, indirect 
supervision, and unsupervised steps.  Figure taken from Louie, 2009 (7) 
 
 
Louie asserts that it would be wise to develop screen and treat programs 
as opposed to a three visit strategy in an effort to avoid loss to follow up (7).  
Furthermore, it was determined that screening with either one or two visits during 
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 “a lifetime using visual inspection or HPV DNA test 
coupled with immediate cryotherapy for screen women 
aged 35 years or older has the potential to reduce the risk 
of cancer by 25-35% compared with no screening” (7).  
 
 
The model that had been used for this study was cost-effective and had 
been conducted in five developing countries in Sub-Sahara Africa.  
While screen and treat programs are very promising for developing 
nations with high rates of cervical cancer, several barriers to access exist as well 
as limitations within the screening programs. Poor staffing and training, lack of 
on-site equipment, and lack of health education among community members are 
just a few of the barriers for success in Sub-Sahara Africa. In a study conducted 
in the Kabalo district of Zambia, it was found that mainly male workers run the 
clinic, which can deter potential female patients from coming to the clinic. A 
strong association was found between a female’s attitudes towards male workers 
as well as the use of services that are conducted predominantly by males (13). 
Such a gender bias in the work place led to a barrier of access to the clinic for 
some females. The facilities in Kabalo are also very poorly staffed. It was found 
that of the fourteen clinics, two have clinical officers and only one clinic as a 
trained midwife (13). In order to cater to the entire patient population that needs 
care, many more officers and clinicians are needed. Sustaining the clinic by 
preventing high physician turn over also exists as a barrier for the screening 
clinics (12). In addition to the lack of proper staff in screening and prevention 
clinics, the lack of equipment poses a barrier to healthcare. A study conducted in 
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2006 in Africa found that a lack of vaginal instruments and medical supplies, 
inability to conduct blood transfusions, and inability to treat shock with fluids, all 
prevented the clinics from operating at an acceptable rate (10).  Additionally, 
water shortages within the hospital, waste disposal and sanitation issues, as well 
as the difficulties with timely delivery of medical supplies negatively affected the 
efficiency and effectiveness of clinics (12). Barriers exist on the patient side of 
care, as well. Reasons for patients not being present for evaluations and 
screenings included: fear of the procedure itself, travel costs in order to get to the 
hospital or clinic, difficulty in getting to the clinic by other means such as walking 
or transportation, and difficulty getting partner or family support for treatment 
(12). Lack of HPV and cervical cancer education among women also exist as a 
barrier to care. A study conducted in 2006 in Kinshasa of the Dominican Republic 
of Congo found that the majority of women who enrolled in a health education 
session had never used any sexual contraceptives and only 3% of the women 
who had used a contraceptive had used one that was medically approved (10). 
Such low use of contraceptives indicates that educational programs regarding 
healthy sexual practices should be implemented in these areas. Of the women 
who visited the clinic, only 5% had received some form of health education, 
which may imply that among those who did not visit the clinic, even a lower 
percentage had received health education (10).  Many women in Sub-Sahara 
Africa, and more specifically in Zambia, are becoming more aware of HIV and 
risk factors associated with it. For this reason, it is important to link HIV education 
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to HPV and cervical cancer education. Individuals who are HIV positive are more 
prone to developing HPV and cervical cancer, as well (12). Screen and treat 
programs and other screening measures have the potential to prevent and 
eradicate most cervical cancers, but severe barriers limit their success.  
 
Barriers Such As The Level Of Education, Women’s’ Misconceptions About 
Cervical Cancer, Gender Inequality, Resource Deprived Settings, And 
Foreign aid  
Akinyemiju conducted a study in 2012 to analyze data from the World 
Health Survey of 2003. He wanted to assess the determinants, specifically socio-
economic and health access, of cervical cancer screening and prevention in low-
income countries, including African countries (15). It was found that an alarmingly 
low percentage, 4.1%, of women between the ages of 18 to 69 had received 
cervical cancer screening (15).  Figure 7 below shows the breakdown of pelvic 
and mammography exams among different low-income nations. As can be seen, 
countries of sub-Saharan Africa, including Kenya, Malawi, and Ghana, have 
much lower rates of pelvic examinations as compared to other low-income 
countries.  
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Figure 7:  Percentage of Mammograms and Pelvic Exams by Country .  
Comparison between the percentage of women in various countries who obtain 
mammograms and pelvic exams; Low-income countries, specifically, are being 
assessed.  Figure taken from Akinyemiju , 2012 (15)  
 
 
The survey also captured a wealth of information regarding the 
demographics, health status, access to health services, and risk factors that may 
increase the likelihood of women developing cervical cancer.  The risk factors 
and determinants can help to explain the underlying barriers of access to care. 
For example, factors may increase the likelihood of not obtaining a pelvic exam 
include (i) being older than 60 years, (ii) having less than a secondary education, 
and (iii) not having seen a nurse or midwife at the last health center visit (15). In 
additional to the level of education of women in African countries, other stagnant 
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barriers to health care access also exist. Women’s misconceptions regarding 
cervical cancer, gender norms and inequality in African nations, as well as socio-
economic status and foreign aid all play major roles in the successful 
implementation of the cervical cancer screening process. Barriers need to be 
eliminated, or, at the very least, drastically reduced in order to allow for proper 
development of cancer screen and treat clinics.  
Correlations between low literacy and education levels in low-income 
countries and not receiving a pelvic exam exist. According to the World Survey of 
2003, 70.7% of women who had only completed a primary school level of 
education did not receive a pelvic exam, compared to 24.9% of women who had 
completed a secondary level of education (15). While there is a distinction 
between overall education level and education regarding the importance of 
obtaining a pelvic exam, the trends are still meaningful.  According to the United 
States Department of Education, “low literacy is an important but frequently 
overlooked factor that influences preventative health and cancer screening 
behavior” (16). In 2002, the Department conducted the National Adult Literacy 
Survey, in which it was found that a higher level of knowledge, specifically 9th 
grade or above was in fact independently associated with accurate knowledge 
regarding the Pap test (16). Additionally, a higher proportion of women who had 
a more adequate level of literacy indicated they would seek medical care about 
any abnormalities compared to that of women who had lower levels of literacy 
(16). Even though this information was gathered in the United States, similar data 
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has been found in African countries. In essence, the education and literacy rates 
of women play a role in their ability and willingness to obtain pelvic exams and 
cervical cancer screening.  
A lack of proper education, especially among women in Sub-Sahara 
Africa, has led to misconceptions about the causes of cervical cancer. The 
misconceptions exist as barriers to healthcare. In 2009, a community-based rapid 
assessment was conducted in Zambia in an effort to understand the common 
myths and causes of cervical cancers. Peer educators led the assessments and 
asked unscreened women two questions during home visits. The questions 
included what the women thought causes cervical cancer and why they had not 
been screened (23). Some of the responses have been documented in Table 3.  
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As can be seen by Table 3, many unscreened women’s’ interpretations of 
cervical cancer are inaccurate and may can be classified as socially constructed 
(23). Fear of the screening process, misunderstanding of the causes of cervical 
cancer, and social stigma around cervical cancer are all barriers to the 
acceptance and use of screen and treat programs.  The peer educators sought to 
convey the importance of obtaining a screening since cervical cancer can be 
prevented and potentially cured if it is detected early enough (23).  
Socially constructed gender norms and gender inequality in African 
countries also exist as barriers for women to obtain pelvic exams and cervical 
cancer screenings. The World Bank published a Health, Nutrition, and Population 
Discussion paper in 2000 that outlined women’s health issues, and the findings 
can be applied broadly to women from all nearly all countries (11).  The paper 
states that women’s health is determined by various factors including individual 
behavior, biological factors, social and cultural influences, and nutrition (11). 
Biologically, women are at higher risk for contracting sexually transmitted 
infections and HIV as compared to men. Additionally, women in Sub-Saharan 
African countries are subject to increased risks related to pregnancy, and it has 
been estimated that one out of seven women will die due to pregnancy-related 
complications. Figure 8 below summarizes the main lifetime health problems 
categorized by age groups for women (11).  Reproductive health problems 
continue to be the worst among the poorer nations; most of the issues relate to  
reproductive health, including HPV and cervical cancer, can be prevented or 
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treated in a cost-effective manner (11).  The low socio-economic status of 
women in low-income countries, unequal power in sexual relationships, and 
biological predispositions of women make them more vulnerable to unwanted 
pregnancies, STIs, and other unwanted medical conditions, such as HPV and 
cervical cancer (11). In some cultures of Sub-Sahara Africa, including in Zambia, 
some women are discouraged from seeing male health providers (13). Since the 
majority of health care providers are male, this poses yet another barrier to 
access to care.  
 
 
Figure 8:  Lifetime Health Problems of Women.  The lifetime health problems 
of women world wide are being depicted within certain categories and stages of 
life.  Figure taken from National Institute of Health, 2013 (33) 
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Social gender inequality exists to a great degree in African countries. 
According to the Social Institutions and Gender Index, a high level of sexual 
violence towards women exists in Zambia. Based on the 2007 Demographic 
Health Survey, 64% of women reported that they had been victims of sexual 
violence either by their husband, partner, boyfriend and even relative (34).  The 
apparent disparity in gender norms and rights can be seen by Zambian 
government reports. In 2010, the Zambian government had reported that a 
husband would have absolute rights over children and reproductive rights over 
his wife once he had made payments for a bride (34). Furthermore, while 
polygamy is not legally permitted in Zambia, it is unofficially accepted in society 
(34). Efforts have been made to decrease and prevent acts of sexual violence in 
the country. However, it has been reported that women often are “pressured by 
law enforcement into withdrawing complaints” (34). Gender inequality and sexual 
abuse can lead to higher cases of STIs, HIV, and HPV, and decrease the 
likelihood that women will seek medical attention and obtain pelvic exams.  
Geographical barriers to HPV clinics and resource deprived settings exist 
as a prominent problem, especially in the Kabalo District of Zambia. Between 
1998 and 2000, a cross sectional study regarding women’s health services was 
conducted in the Kabalo district and it was found that several geographical 
barriers prevented women from seeking care (13). Most of the terrain in the 
region is swamp-like and heavy flooding throughout the year is common. After 
flooding occurs, communities on either side of the flood plains become 
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geographically separated, making clinic visits to either side very difficult (13). 
Lack of proper resources and methods of transportation also discouraged women 
from seeking care at the clinic in Kabalo. According to a survey conducted by 
Stekelenburg and colleagues, 76% of respondents stated that they had to walk to 
the clinic, and 50% of those who had to walk, had to walk for at least two hours in 
order to reach the clinic (13).  Therefore, access to the clinic required a great 
deal of physical effort, and many women felt discouraged to seek care at an 
institution because of this barrier.  The perceived quality of care also influenced 
women’s decision to travel to the clinic; if their perception of the clinic was poor, 
then they were less likely to make the effort to seek care (13). 
The high level of poverty and resource deprivation in Sub-Sahara Africa also 
largely impacts the accessibility of screen and treat clinics for HPV and cervical 
cancer. Table 4 below outlines the percentage rates of poverty in Zambia from 
1991 to 1998 (18).  Low poverty rates contribute to the inability of some women 
to seek care. According to Stekenberg, the cost of services plays a large role in 
the decision-making process of going to the clinic. For the majority of women, the 
fees were not affordable and they did not seek and receive the care that they 
needed (13). Over two thirds of Zambian families have a monthly income under 
500,000 Zambian Kwacha, which is equivalent to $100 U.S. dollars (12).  Such 
an amount is not sufficient for a healthy lifestyle, let alone payments for clinical 
visits. According to Pfaendler’s study, roughly 75% of Zambian women were 
familiar with the term “cervical cancer.” However, the greatest barrier to care is 
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that facilities for early detection and treatment for cervical cancer in Sub-Sahara 
African settings does not exist for most women (12).  Zambia is of particular 
interest because it has the second highest incidence rate of cervical cancer world 
wide, at 1,839 per 100,000 people. It ranks second to Guinea (19).  
 
 
Table 4:  Poverty Levels in Zambia.  Rural and urban overall and extreme 
poverty levels (%) are shown between the years of 1991 and 1998.  Table taken 
from  Pitamber, 2006 (18), 
 
As can be seen by Table 5 and Figure 9, there are correlations between 
high incidence rates of cervical cancer and high poverty.  
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Figure 9: The Number of People Living on Less Than $1.25 per Day World-
wide. Shown are the areas were poverty is rampant and Sub-Saharan Africa is 
the highest. Figure taken from World Bank, 2013 (37). 
 
Foreign aid has successful helped with improving the issues of HIV/AIDS, 
malaria, and tuberculosis.  However, Macgrath asserts that cancer care requires 
a more individualistic approach, and successful cancer treatment would involve a 
team of skilled experts (6). Cancer treatment is also very difficult because of its 
high cost. Low-income nations, including Zambia, have assigned a low priority to 
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cancer control, resulting in an unfortunate situation in which poor access to care 
results in patients having more severe cases of the disease; since the disease is 
more severe, this leads to increased costs and toxicity of treatments which leads 
to lower survival rates overall (6). In an effort to make clinical services affordable 
and accessible, the Zambian government introduced free health care in rural 
areas in 2006, which was made feasible by the British charity, Oxfam (14). While 
the barriers of lack of education, misconceptions regarding causes of cervical 
cancer, gender inequality, and resource deprivation exist, foreign aid helps 
relieve mainly the barrier of resource deprivation.  
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DISCUSSION 
 
Correlation between the Human Papilloma Virus, Human Immunodeficiency 
Syndrome, and Cervical Cancer  
 Numerous studies have indicated the strong association between HPV and 
cervical cancer.  According to Rudlowski, specific types of HPV (high-risk HPVs, 
and lower extent low-risk HPVs) have been detected in a transcriptionally active 
form in about 95% of cervical cancer biopsies 4).  Since even low-risk HPVs are 
detected in cervical cancer biopsies, early detection of HPV would be extremely 
beneficial to women who have any range of risk HPVs in an effort to prevent the 
development of cervical cancer. Other studies have indicated that virtually 100% 
of cases of cervical cancer are caused by HPV, implying that HPV testing and 
detection would largely prevent the progression of lesions (17). Ultimately, this 
would reduce the high incidence rate of cervical cancer in Zambia and in other 
Sub-Saharan African countries and likely eradicate it in the US.  In areas where 
cytology programs are either non-existent or not efficient, HPV testing 
approaches should be evaluated and implemented (5).  The high prevalence of 
HIV is correlated with HPV in part because of the similarity in transmission; both 
HIV and HPV are sexually transmitted viruses. HIV is also associated with more 
severe classes of HPV including those associated with cervical neoplasia and 
invasive cancer (20).   AIDS also disproportionally affects women, making them 
more vulnerable to sexually transmitted diseases as well as HPV (18). Because 
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of the high prevalence and awareness of HIV in Sub-Saharan Africa, many AIDS 
relief and Global Funds Programs currently exists updating healthcare 
infrastructures in some areas of sub-Saharan Africa (20). The HIV/AIDS 
infrastructure that has already been established in developing countries can be 
used as a sound basis for the further development of HPV and cervical cancer 
prevention and treatment. Existing awareness of HIV among sub-Saharan Africa 
communities can aid in the push for awareness of HPV and its health 
implications. This would be especially important in Zambia since it has one of the 
world’s highest incident rates (20).  Furthermore, since HIV- infected women are 
at greater risk for becoming infected with HPV, the impact of ART on HPV should 
be evaluated since ART is being used to treat HIV (7). Additionally, education 
linking HIV to HPV and further cervical cancer education is a crucial element of 
preventative measures (12).  While HIV treatment is largely accepted in sub-
Saharan Africa, the acceptability of HPV vaccinations and cervical cancer 
screenings will require persistent efforts by community health workers, 
physicians, and the government. Other vaccine deployment considerations 
include channels of vaccine deliveries, strategies, etc. many of which can be 
modeled after HIV programs that have already been established (7).  By 
collaborating with other HIV care and treatment leadership teams, the 
organizational history of the HIV treatment and care program can be determined, 
and suitable infrastructure can successfully be applied to new HPV treatment and 
care programs (20). However, adjustments would need to be made since cancer 
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prevention is much more costly, as compared to HIV care, and requires a more 
individualistic approach depending on the patient’s particular medical case (20). 
 
The Accuracy and Feasibility of “Screen and Treat” Programs  
 While all screening methods are viable options, some approaches may be 
more feasible and less costly than others. According to Table 1, the 
methodological approaches of VIAM, VIA, Pap Screening, HPV screening, and 
Cervicography are all safe (9). However, VIAM and VIA are the only two that are 
also practical, affordable, and available. Affordability is the major concern when 
implementing screening programs in sub-Saharan Africa; for this reason, either 
VIAM and VIA would arguably be the best options as long as they were effective. 
Table 2 depicts the specificity and sensitivity of the VIA, VILI, VIAM, Pap Smear 
and HC2 methods (8). According to the data, the VILI approach had the highest 
pooled level of sensitivity while the Pap smear had the highest pooled level of 
specificity; the VIA approach had high levels of both measures (8). Both 
measures of sensitivity and specificity are important indicators of the accuracy of 
screening tests, and one is usually sacrificed for the other (35). In another study 
conducted by the International Agency for Research on Cancer, it was shown 
that up to 90% of the cancerous lesions can be identified by the VIA method 
however they went on to state that the specificity, or reduction of over-treatment, 
was more valuable than the sensitivity especially in light of limited resources.to 
pay for screening tests (9). A sensitivity level between 70% and 80% and a 
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specificity level of 90% to 95% was considered reasonable (9). Based on these 
values, the VIA would be considered the most appropriate method in terms of 
screening procedures (9). The VIA method has the advantage of giving 
immediate results that can be applied to large populations (20). Various studies 
have also validated the efficacy, acceptability, and overall cost-effectiveness of 
the VIA screening approach (20).  Lifetime costs associated with different 
screening approaches vary depending on the country (22). Screening tests are 
most cost-effective when the linkage between screening and treatment is 
enhanced, which is the case for VIA screening approach (22). Screen and treat 
methods that consist of only one visit, are more preferable than methods that 
require multiple visits since follow-up may pose a problem for multiple visit 
procedures (7). While VIA is arguably the best screening method, the LEEP has 
been shown to effectively remove cancerous lesions, and can be implemented 
into screen and treat programs (12). As can be seen by Figure 6, LEEP involves 
didactic training, observations of LEEP conducted by skilled personnel, extensive 
practice, and performance of LEEP with supervision by skilled personnel will lead 
to the eventual practice without supervision (7). The overall process is thorough, 
precise, and easy to implement. Physicians are carefully observed and 
supervised as to ensure proper technique and quality of care for the patients (7). 
Therefore, it can be easily implemented into screen and treat programs if proper 
staff and equipment are also provided.  However, several issues regarding the 
screen and treat programs exist, according to various studies, and the issues 
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need to be addressed in order to increase the efficacy of the clinical programs. It 
was found that healthcare facilities in the Kabalo District of Zambia are severely 
under-staffed and face a high turn over rate (12). Increasing the number of staff 
members, properly training them, and providing incentives to continue working in 
the clinic for long periods of time would help to reduce this issue (13).  The lack 
of adequate medical supplies may also be a contributing factor to the issue of a 
high turn over rate (10). Physicians may feel unprepared or incompetent to 
perform surgeries and screenings without the proper equipment. Furthermore, 
water shortages and waste disposal issues within the clinic can reduce the 
perception of quality of care for patients, thereby discouraging patients from 
going to the clinic (12). Sanitation issues within clinics also discourage physicians 
from working in such locations. The demographic composition of the staff in 
clinics can also discourage women from attending appointments. Specifically, in 
some regions of Zambia, women are discouraged to seek care from male 
physicians (13); cultural customs such as these detract a large number of women 
from seeking care when they need it. Training and hiring more female physicians 
and staff members in clinics can help to eliminate this particular issue.  
Addressing and improving the limitations of screen and treat clinics may help to 
increase the number of women who actually seek care at the clinics.  
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Barriers of Lack of Education, Women’s’ Misconceptions About Cervical 
Cancer, Gender Inequality, Resource Deprived Settings, and Foreign Aid 
and Funding  
The fundamental barriers of a lack of education, culturally produced 
gender inequalities and misconceptions about cervical cancer, and lack of proper 
resources exist as root causes for such high incidence rates of cervical cancer in 
Zambia and other countries of sub-Saharan Africa. In a study conducted by 
Sangwa Lugoma, it was found that only three percent of a group of women in 
Africa had used a contraceptive that was medically approved (10). Such a low 
percentage reflects the unavailability of proper resources and contraceptives, as 
well as a lack of education regarding sexual practices. Since the education levels 
and literacy rates of women affect their willingness and ability to seek HPV and 
cervical cancer screenings, more attention and financial aid needs to be given to 
the education sector of Zambia and other countries of sub-Saharan Africa. 
Currently, the education sector of Zambia is  very weak as children often have to 
travel long distances to reach the school, often have to care for family members 
in addition to the fact that they tend to work in order to contribute to household 
income (18). The low enrollments and high dropout rates are seen especially 
among young females. The lack of proper education in some areas, including sex 
education, has in part led to drastic misconceptions about the causes of cervical 
cancer (23). Table 3 depicts Zambian women’s responses to the questions of 
what they think causes cervical cancer and why they have not been screened; 
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their responses are far from remotely accurate. Based upon the responses, it 
seems as though cervical cancer is a condition that is greatly stigmatized within 
Zambian societies (23). Women hold negative beliefs and attitudes regarding 
cervical cancer, and they associate it with being unclean as well as a reflection of 
bad behavior. In general, cervical cancer is stigmatized beyond its true medical 
condition, and this is partially a result due to a lack of proper education for 
women in the region. More recently, in a study conducted in 2012, it was found 
that levels of knowledge regarding HPV vaccines were very low, due to lack of 
public education (21). Overall, there is a great need for increased sex education 
and basic medical education regarding infections in sub-Saharan Africa.  
Improving school infrastructure would also be needed in order for the education 
to occur.  
According to the World Bank, women’s health is determined by various 
factors and they are more vulnerable than men at each stage of their life, 
especially in their reproductive years (11). Figure 8 outlines the major biological 
and social predispositions of women. Gender violence is especially of concern in 
Zambia and other African countries. Reports from the Social Institutions and 
Gender Index conclude that an alarming high percentage of Zambian women 
have been victims of sexual assault (34). Sexual assault may entail having 
unprotected sex, which is a major risk factor for being infected with HPV and 
developing cervical cancer. Since sexual assault is quite high, individuals may 
have many sexual encounters or sexual partners, which is also a major risk 
 45 
factor for HPV and cervical cancer.  Traditionally, Zambian men have 
“reproductive rights over [their] wives” and culturally have “control” over their 
wives’ behaviors (34). If a woman’s husband does not want her to get screened 
for HPV or cervical cancer, she is much less willing and able to go to the clinic. 
Therefore, both sexual violence and gender inequality may be contributing to 
high incidence rates of HPV and cervical cancer despite the existence of screen 
and treat programs.  
Geographical barriers, resource deprivation, and overall extreme poverty 
can prevent women from going to screen and treat clinics. The terrain in Zambia 
and other areas in sub-Saharan Africa can become quite difficult to travel through 
during flood seasons due to geographical separations that are created due to the 
floods (13). Roughly half of the women in one study reported that they had to 
walk, indicating that the clinic was not located in an area that was largely 
accessible. The physical inaccessibility of the clinic discouraged women, who 
were willing, to come to the clinic for screenings. Since not all clinics can be 
comfortably reached, home visits by physicians and/or the utilization of 
community health workers may help to eliminate this particular barrier of access. 
This strategy would be especially beneficial to residents of rural areas since they 
are more likely to live farther away from institutionalized clinics and screen and 
treat facilities and are also more likely to be in a state of extreme poverty (18). 
 The cost associated with healthcare and screenings also affects women’s 
decision about whether or not to seek care. Table 4 depicts the statistics 
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regarding poverty rates in Zambia during the 1990’s (18). Zambia is a low-
income country and healthcare fees are not affordable for most women and 
families. Because most families have very low incomes, they tend to use their 
income on basic necessities, including food, water, and shelter; this leaves 
healthcare as a lower priority since not getting screening for HPV and cervical 
cancer does not seem life-threatening. Not having enough food or water is more 
life threatening, and obtaining food and water persists as a high priority item for 
almost all people (6). The longer patients wait to seek care, the more severe their 
condition becomes, and the care to treat the condition becomes more costly (6). 
Cervical cancer care and treatment is especially costly, and many women of sub-
Saharan Africa do not get screened for HPV well in advance, resulting in high 
incidence rates of cervical cancer. Table 13 and Figure 9 relay the correlation 
between age-adjusted cervical cancer incidence rates and poverty. According to 
Table 5, a significant majority of countries with high rates of cervical cancer are 
located in sub-Saharan African (19). Similarly, Figure 9 illustrates that the region 
with the highest percentage of people living on less than $1.25 per day is that of 
sub-Saharan Africa (37). While these data cannot provide conclusions about a 
cause and effect relationship, it does imply a correlation between high poverty 
levels and vulnerability to cervical cancer.  
 Foreign aid has improved the barrier of resource deprivation to a large 
degree. Contributions made by charities, such as OxFam, and by non-profit 
organizations, such as Partners in Health, have led to the development of sound 
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infrastructures for hospitals and clinics in Zambia, Malawi, and other parts of sub-
Saharan Africa. Large donations by health organizations have also helped to 
create more screen and treat programs in the region, thereby helping to reduce 
the incidence rates of cervical cancer (14). The implementation of free health 
care in rural areas by the Zambian government had a direct positive impact to the 
residents of rural areas, especially women (14). However, the social conditions 
that involve gender inequality, sexual violence, lack of health education, and 
continued misconceptions of cervical cancer still need to be more directly 
addressed and improved.  
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CONCLUSION 
 
 The major aims of this literature-based review were to understand the 
reasons for high incidence rates of cervical cancer in Sub-Saharan Africa and to 
provide meaningful proposals for healthcare access improvement in the region, 
and more specifically preventative techniques. The main focus within Sub-
Saharan Africa was on the country of Zambia, since it has one of the highest 
incidence rates of cervical cancer in the world.  The pathology of cervical cancer 
and HPV were both discussed, as well as the method of transmission of HPV via 
sexual activity. The importance of cervical cancer screening and treatment was 
also heavily discussed. Three main points of interest were analyzed, including: 
the correlation between the prevalence of HIV, HPV and cervical cancer, the 
accuracy and feasibility of screen and treat programs, and lastly, barriers such as 
a low level of education, women’s misconceptions about cervical cancer, gender 
inequality, resource deprivation, and foreign aid.  
 A strong correlation and causal relationship was found between HPV and 
the development of cervical cancer. HIV/AIDS was shown to be a high risk factor 
for becoming infected with HPV since both are can be transmitted via sexual 
contact. The majority of Zambian residents and other residents of sub-Saharan 
Africa were well informed and knowledgeable about HIV. However, a very few 
percentage of residents were aware of HPV and cervical cancer. For this reason, 
it is proposed that cervical cancer and HPV screening programs be modeled 
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after HIV preventative programs since the infrastructure has already been 
established, and this would ensure the optimization of resources and additional 
efficiencies for both of programs (20).  HPV vaccinations are also relevant to the 
screening program since they were found to potentially decrease the number of 
invasive cervical cancer cases among HIV positive women.  Overall, much 
collaboration between successfully running HIV programs and newly developing 
HPV and cervical cancer programs needs to occur.  
 The accuracy and feasibility of several different types of HPV screening 
methods were discussed. The screening methods included: VIA, VILI, VIAM, 
HC2, Pap Smears, and Cervicography. The methods were analyzed based on 
specificity, sensitivity, overall affordability, and feasibility according to research 
studies conducted. It was determined that the VIA approach was the best method 
to use in Zambia. Therefore, it is proposed that HPV and cervical cancer screen 
and treat programs implement the VIA method rather than other methods 
mentioned. Furthermore, LEEP was found to be an important and cost-effective 
method for treating cervical cancer. The development of LEEP in clinics and 
screen and treat programs would involve training of physicians and staff 
members in a step-wise process. LEEP has been shown to effectively remove 
cancerous lesions. It is proposed that LEEP be implemented into cervical cancer 
care treatment programs together with the VIA approach. Both will ultimately help 
to lower the high incidence rates of HPV and cervical cancer in Zambia and sub-
Saharan Africa.  
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 Various educational, social, geographical, and economical barriers were 
also considered in an effort to understand the underlying causes of high cervical 
cancer incidence rates. In Zambia and other surrounding countries, it was found 
that a lack of education, especially among young women exists. Because of this, 
young women have inaccurate and negative misconceptions regarding the 
causes of cervical cancer. The misconceptions contribute to their unwillingness 
and, in some cases, fear of getting screened or treated, which ultimately results 
in higher rates of cervical cancer incidence and more severe cases.  Sexual 
violence, which is highly prevalent in Zambia, leads to unwanted sex and higher 
rates of STI, HIV, and HPV. It was also found that gender inequality also 
contribute to women’s inability to seek care at screening and treatment clinics.  It 
is proposed that educational infrastructures need to be improved and the 
Zambian government and culture needs to encourage women to be educated, 
especially about their own heath. Other barriers of access to care that were 
determined include geographical barriers that make transportation difficult, high 
poverty rates, and resource deprivation. Appropriate funding and foreign aid can 
diminish nearly all barriers. It is proposed that the Zambian government and 
other countries of sub-Saharan Africa utilize and train their own nurses and 
physicians when developing the screen and treat programs. Emphasis needs to 
be placed upon program infrastructure, increasing resources, providing and  
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encouraging young women to attain a high level of education, especially sex 
education, and severely discouraging the practice of sexual violence and 
unprotected sex within Zambia and other regions of sub-Saharan Africa.  
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